India to Latvia: Sofosbuvir Export Trade Route

The India to Latvia Sofosbuvir corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $3.7M USD. The route is dominated by EURO LIFECARE PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's sofosbuvir manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $736.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with sofosbuvir's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 29.5%, placing it at rank #15 among India's top sofosbuvir export destinations globally.

On the import side, key buyers of Indian sofosbuvir in Latvia include SIA "MAGNIPHARMA",, SIA MAGNIPHARMA ELIZABETES IELA, SIA MAGNIPHARMA. SIA "MAGNIPHARMA", is the single largest importer with 3 shipments valued at $1.7M USD.

India's sofosbuvir exports to Latvia are driven primarily by a handful of large-scale manufacturers. EURO LIFECARE PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Latvia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EURO LIFECARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $736.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as velpanat film-coated tablets,400 mg,28 tablets in a bottle,1 bottle in a cardboared box sofosbuvir and velpatasvir 400m and velpanat (24 nos foc)(ws sofosbuvir 300mg and ws velpatasvir 150mg), suggesting that buyers in Latvia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SIA "MAGNIPHARMA", is the largest importer with 3 shipments worth $1.7M USD — representing 45% of all sofosbuvir imports from India on this route.